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Overview
♦ Spaceflight Medical Concerns
• Physiological adaptation to microgravity, partial gravity
• Summary of medical events during spaceflight
♦ Space Vehicle and Environmental and Surface Health 
Risks
♦ Medical Concept of Operations (CONOPS)
• Current CONOPS & Medical Hardware for Shuttle (STS) and ISS
• Planned Exploration Medical CONOPS & Hardware needs
♦ Exploration Plans for Lunar Return Mission & Mars
♦ Developing Medical Support Systems
• Preventative Health Strategy
• Autonomous Care
• Analog Sites for Exploration
Our Destiny is to Explore!
♦ The goals of our future space flight program must be worthy of the 
expense, difficulty and risks which are inherent to it.
♦ We need to build beyond our current capability to ferry astronauts 
and cargo to low Earth orbit.
♦ Our steps should be evolutionary, incremental, and cumulative. 
♦ To reach for Mars and beyond we must first reach for the moon.
A committed and long term lunar effort is needed, and we 
need to begin that investment now!
♦ Total space flight time to 23 August 2004: 27,302 crew-days (74 
crew-years) 
• Persons who have flown in orbit: 433 (does not include repeat 
fliers) 
• As of STS 107 there were  6254 person days on Shuttle (1981-
2003)
♦ Skylab experience – 504 person days
♦ NASA Mir – 849 person days 
♦ US ISS – 1390 person days
Human Experience in Space
♦ Physiological Issues in Microgravity
• Space Motion Sickness (SMS)
• Cardiovascular
• Neurovestibular
• Musculoskeletal
• Immune/Hematologic
• Psychiatric
Space Medical Issues- Past & Present
Space Motion Sickness (SMS)
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Space Motion Sickness
Causes (possible)
• Neurovestibular
− otolith mismatch
− sensory conflicts
• Fluid shift
Space Motion Sickness Categorization
USA USSR/Russia
ASTP: Apollo-Soyuz Test Project
♦ Mild SMS:
• One to several transient symptoms
• No operational impact
• All symptoms resolved in 36-48 hrs
♦ Moderate SMS:
• Several symptoms of a persistent nature
• Minimal operational impact
• All symptoms resolved in 72 hrs
♦ Severe SMS: 
• Several symptoms of a persistent nature
• Significant performance decrement
• Symptoms persist beyond 72 hrs
Cardiovascular Effects
Fluid Shifts during Space Flight
On Earth, gravity 
exerts a 
downward 
force to keep 
fluids flowing 
to the lower 
body. 
In space, the fluid tends to 
redistribute toward the 
chest and upper body. 
At this point, the body 
detects a “flood” in and 
around the heart.
The body rids itself of this 
perceived “excess”
fluid.  The body 
functions with less fluid 
and the heart becomes 
smaller. 
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Upon return to 
Earth, gravity 
again pulls the 
fluid 
downward, but 
there is not 
enough fluid to 
function 
normally on 
Earth.
Neurovestibular System

Physiological Events and Piloting
Landing performance:
- Initial apparent correlation of length of shuttle mission and landing 
outside or nearly outside parameters (landing too fast, landing too 
slow, landing hard)
- Upon further study, correlation not verified (however, there was one 
very short mission that had bad landing parameters that may have
skewed the data considering the small number of data points) 
- What is verified is that actual landing performance shows much 
greater variability than simulator performance parameters
- The implication is that spaceflight has an effect on pilot 
performance- and now is correlating with post-flight 
neurovestibular measures
Physiological Events and Piloting
STS 108 Heads Up Display (HUD) on final approach
Neurovestibular
♦ Lunar Surface 
Operations
• Crews generally felt a little 
“wobbly” upon stepping on the 
moon
− Coordination seemed to 
improve steadily during first 
couple of hours on the 
surface 
• Crews denied problems with 
spatial disorientation on lunar 
landing
Bone Loss during Spaceflight
♦ Vostok: Increased fecal and urinary calcium first noticed
♦ Gemini: Loss of approximately 2-4% of bone mass in heel after 4-11 days of spaceflight
♦ Apollo: 3-5% decrease in bone mass after 10 days
♦ Soyuz: 8-10% decrease in bone density
♦ Skylab: 1-3% per month loss in bone mineral
♦ Mir: 10% loss of trabecular bone from lumbar spine in one cosmonaut
after a 1-year mission
♦ Shuttle-Mir:
• With countermeasures: 5.4% decrease in bone density in tibia. Did not return to 
preflight level in some individuals
• Without countermeasures: 1.3-1.5% per month decrease in bone density (worst case: 
15-22%  total in some bones)
♦ ISS: Preliminary data similar to Shuttle-Mir
Bone Ca Balance (Vo+ - Vo-)
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Bone Ca Loss ~ 250 mg/d
Bone Ca Gain ~ 100 mg/d
Recovery: 2-3 x mission
Bone Health assessments after 
an early Phase I mission (cont.)
Musculoskeletal System Loss and Potential 
Complications/ Countermeasures
♦ Treatment for Acute Symptoms
• Stretching
• Exercise
• Penguin Suits
• Fetal Position Sleep Strap
• Medications: e.g. NSAID- Rx for discomfort
♦ Countermeasures in Practice
• For Muscular strength and endurance preservation
− Resistive exercise
− NAC and other supplements/pharmacologics
• For cardiovascular system and aerobic capacity maintenance
− Cycle/treadmill/rower, other whole body exercise 
capability
• For Reduced bone strength/ Increased Injury or Fracture Risk:
1) Resistive exercise hardware
2) Pharmacologic- e.g. Bisphosphonates
♦ For Urinary Calcium Excretion- Risk of Calculi
1) Fluid Intake
2) Resistive exercise
3) Pharmacologic- e.g. inhibitor K+ Citrate or K+MgCitrate
4) Contingency Management Strategy
♦ Countermeasures under consideration/ preparation
1) Artificial gravity in transit
2) PTH, Peptides
Immune System
♦Among the possible causes of space flight-
induced alterations in immune responses are 
• exposure to microgravity
• exposure to stress
• exposure to radiation
• and many more as yet undetermined causes 
Sonnenfeld G. The immune system in space and microgravity. Med Sci Sports Exerc. 2002 Dec;34(12):2021-7.
Hematopoietic system
♦Reduction in Circulating 
Red Blood Cell mass
• “Space Flight Anemia”
Udden MM, Driscoll TB, Leach-Huntoon CS, Alfrey CP. Decreased 
production of red blood cells in man exposed to microgravity. 
New England Journal of Medicine, 1994.
Lawrence Rice, Clarence P. Alfrey. Modulation of red cell mass by 
neocytolysis in space and on Earth. Pflugers Arch- Eur. J. 
Physiol., 441 (Suppl):R91-R94, 2000. 
Psychiatric
♦ Changes in crew mood, morale, and circadian 
rhythm
♦ Incidence - Affects all crewmembers to some degree
♦ Symptoms - Fatigue and irritability 
♦ Time course - Depends on flight plan
♦ Causes
• Work load
• Sleep habits and facilities; chronobiology
• Crew personalities and “crew space”
• Temperature
• Noise
• Odors
• Atmosphere
• Diet
• Lack of family contact
♦ Treatment - Treat causes
Physiological Issues in Partial 
Gravity
♦ Apollo lunar crews adapted 
quickly to the 1/6g environment
• Initial unsteady gait related to EVA 
suit CG issues not neurovestibular 
dysfunction
• Forearm and upper extremity 
fatigue attributed to glove design
• Inadequate sleep, dietary caloric 
intake experienced by most 
crewmembers
• Other physiologic function 
(cardiovascular, bone) unknown
♦ SMS did not recur upon return to 
microgravity
Health-Impact Events in Flight
♦ Medical Evacuation
• 3 Russian medical-induced vehicle evacuations
♦ Near misses
• Cardiac event on-orbit, Heart Attack 6 weeks post-flight
♦ Medical with mission impact
• Apollo 13 – Kidney infection during mission
♦ Neurologic consequences of Spaceflight
• Impaired cognitive performance aka “Space Fog” or “Space Stupids”
♦ Behavior and performance
• STS payload specialist despondent when payload experiment failed, crew 
concerned about potential for dangerous behavior
♦ Medication events
• Excessive medication use prior to EVA
♦ Fouled Atmosphere
• Fire, toxic release, etc.
♦ Thermal Issues
• Hyper- and hypo- thermia
Medical Symptoms in US Space 
Program
♦ Shuttle program (89 missions) 1981-98:
♦ 508 crew (439 men, 69 woman) over 4443 flight days 
(includes repeat fliers, does not include 1998-2005)
• No medical evacuations to date, but multiple mission impact 
events
• 79% reported space motion sickness
• 98% reported some medical symptom
− 67% headache
− 64% respiratory complaints
− 58% facial fullness
− 32% gastrointestinal complaints
− 26% musculoskeletal complaints
− 12% injuries
− 10% genitourinary symptoms
Medical Events in Flight – Medical 
with Mission Impact
• Apollo  -- EVA rescheduled due to motion sickness 
• Apollo  – Type 1 DCS in command module pilot
• Apollo  – Urinary tract infection during mission
• Apollo  – Cardiac irregularity during lunar EVA
• Salyut- Kidney Stone- 1982
• Shuttle -- 4 cases of urinary retention resulting in bladder 
catheterization
• ISS -- Crewmember pulled from EVA due to cardiac 
abnormalities
Medical Events in Flight –
Near Misses
• 1 cardiac ischemic event within 3 days of launch (crew 
changed out)
• 2 cardiac ischemic events inflight, followed by 
myocardial infarction (MI) postflight
−Case 1: acute diaphoresis, fatigue and bigeminy on 
orbit, Myocardial Infarction 2 years post flight
−Case 2 event treated with ASA and beta blocker, 
Myocardial Infarction 6 weeks post flight
Medical Events in Flight – Medical 
Evacuation from Space
♦ Salyut 5 space station (1976) abandoned 49 days into 
54 day mission for intractable headaches following 
probable combustion event 
♦ Salyut 7 space station (1985) evacuation 56 days into 
216 day mission for urinary tract infection
♦ Mir space station (1987) evacuation 6 months into 11 
month mission for heart irregularity
Health Risk during EVA
♦ Separation from space craft
♦ Micrometeoroid/ orbital debris (MMOD)
♦ Foreign body Injury (inhalation, ocular)
♦ Worksite injury (crush, electrical)
♦ Contact with Toxic Substances 
♦ Hypobaric space suit pressure
♦ Life Support System failures
♦ Suit leaks in Vacuum
♦ Thermal Injuries 
♦ Light Glare/ Darkness
♦ Radiation
Suit Trauma
♦ Existing Space Suits cause significant trauma to crew members
• Oncholysis-Finger nail damage
• Shoulder and other orthopedic injuries
• Bruising, abrasions, parathesias
♦ Minimize movement and point loading within suit
♦ Ensure suit kinematics are designed in conjunction with human 
biomechanical considerations
♦ Lower operating suit pressures
♦ ? Form-fitting, inflate to fit LCVG
♦ Space Environment
Reduced or Micro / Zero Gravity
Radiation (GCR / SPE)
EVA Extravehicular Activity (Spacewalks)
Vacuum (Pressure D)- Decompression 
Sickness
Micrometeoroids / Orbital Debris
Interplanetary microbial life (??)
♦ Space Craft Environment
Toxic Atmosphere
Impaired Gas Concentration ( O2, CO2)
Combustion
Thermal
Isolation and confinement
Noise and Vibration
Closed loop environment (life support)
Payloads and construction activities
Waste production
♦ Space Flight
Remoteness and time passage / communication 
delay
Flight activity (propulsion, G-forces, impacts)
Circadian / Schedule changes
Possible Hazards of Long Duration 
Space Flight
LEO: Radiation Exposure protection 
from the Geomagnetosphere, Not on Mars!
Radiation Safety and Protection
♦ Module dose monitors
♦ Small, lightweight detectors with 
EVA teams
• Alarms integrated into suit CnW
• Best on rover vs. PLSS of each 
suit?
♦ Early warning satellite network
• Improved modeling for prediction of 
progressive events
• Not all X-ray flares are followed by 
energetic protons
♦ Deployable shielding 
• On rover
• ? Walkback portable shield
♦ Radioprotectants
Biologic Effects of Radiation Exposure
♦ Immediate and Delayed Effects
• Direct
− Largest cellular target- Nucleic Acids
− Lethal events (esp. if large track or clustered hits)
− High, acute dose (overwhelm defenses, often lethal)
− Chronic, low dose (mutations-cancers)
• Indirect
− Reactive Oxygen Species
− Lipid Peroxidation
− DNA Methylation
♦ How do we quantify the effects: Biodosimetry
♦ Health Risk associated with exposure
• Based on extrapolations from nuclear accident and weapon exposure data
• Cancer risks have significant uncertainty
Other Environmental Issues 
“Those that do not read and understand history are doomed to repeat it”
– President Harry S. Truman
♦ Apollo 1 fire
• 100% oxygen at sea level pressure
• Lack of materials control
♦ Apollo 13
• Critical consumables location
• Multiple hardware developers
− CO2 removal
♦ Shuttle, Shuttle/Mir, ISS experiences
Lunar Dust
Why are we concerned?
¾ Dust particles levitated at the lunar 
terminator, perhaps due to polarity changes 
(Criswell ’72). 0.16 G at lunar surface, where 
there is a layer of fine particles that are 
easily disturbed and placed into 
suspension. These particles cling to all 
surfaces and pose serious challenges for 
the utility of construction equipment, air 
locks, and all exposed surfaces (Slane ’94)
¾ After lunar EVA the crewmen and the 
samples they had collected were covered 
with fine lunar material. Despite attempts at 
clean-up and packaging in the LM, transfer 
of crew and materials back to the CM 
resulted in contamination of the CM 
atmosphere (Brady et. al, 1975)
¾ Apollo astronauts were not in the lunar 
environment long enough to develop the 
clinically significant, dust-related 
symptoms. However, during upcoming 
missions, crews will be on the Moon for 
months at a time. 
¾ Properties
¾ Size, shape, lack of weathering
¾ Possible reactivity- volatiles, solar protons
Space Medical Issues- Future 
Concerns
♦ Expected illnesses and problems
• Orthopedic and musculoskeletal 
• problems
• Infectious, hematological, and 
immune- related diseases
• Dermatological, ophthalmologic, 
and 
• ENT problems
♦ Acute medical emergencies
• Wounds, lacerations, and burns
• Toxic exposure and acute 
anaphylaxis
• Acute radiation illness
• Dental, ophthalmologic, and   
psychiatric
♦ Chronic diseases
• Radiation-induced problems
• Responses to dust exposure
• Presentation or acute manifestation 
of nascent illness
Medical Concept of Operations for 
Exploration (CONOPS)
♦Our mandate:
• Optimize crew health and 
performance to ensure 
mission success
• Return the crew safely to 
Earth
Medical Operational Concept
♦ Prevention is Key
• Crew selection/retention standards will be used to 
minimize likelihood of medical conditions developing 
during or after mission. 
• Preflight testing and conditioning of crew will be 
performed prior to launch to ensure that they are in 
the best physical and psychological condition prior to 
launch. 
• Crew training will be conducted by medical doctors to 
provide the crew, especially the Crew Medical Officer, 
with the best skill set to take care of medical 
contingencies 
• Behavioral health and family support specialists will 
work with crew to ensure their psycho-social needs 
are met 
Guiding Philosophy: 
Prevention; Prevention; Prevention 
(with a little Prophylaxis mixed in)
♦ Revised selection and mission medical standards
♦ Improved pre-flight medical readiness program
• Fitness
• Optimization of health
• Crew rest???
♦ Better system design to reduce crew overhead
• Reduce fatigue
♦ Emphasis on safety
• Vehicular components
• Mission Planning, esp. EVA
• Flight Rules
♦ Maintenance of Performance
• EVA
• Re-entry
• Recovery
Hospital
Polar Ops
Submarine
Ambulance
Everest
Diagnostics    Therapeutics   Communication    Evacuation   Personnel
Current Capabilities
Current Medical Capabilities 
Comparison

The Moon - the 1st Step to Mars and 
Beyond….
♦ Gaining significant experience in operating away from 
Earth’s environment
• Space will no longer be a destination visited briefly and 
tentatively
• “Living off the land”
• Human support systems
♦ Developing technologies needed for opening the        
space frontier
• Crew and cargo launch vehicles (125 metric ton class)
• Earth ascent/entry system – Crew Exploration Vehicle
• Mars ascent and descent propulsion systems (liquid oxygen       
/ liquid methane)
♦ Conduct fundamental science
• Astronomy, physics, astrobiology, historical geology, 
exobiology
Next Step in Fulfilling Our Destiny As Explorers








Medical System- Hardware Elements
Lunar Sortie- Lander:
• Ambulatory Medical Kit (Routine symptom response: HA,  
• Medical Contingency Kit (Trauma management; O2 concentrator, AED)
• Environmental Response Equipment
− Airlock EVA Contingency Response (Contamination Clean-up, PPE  and 
Contamination or Decompression Sickness Medical Kit)
− Contingency Breathing Apparati (4-portable or umbilical-based devices)
− Eyewash (system to flush contaminants from crew)
Lunar Outpost- Long duration Habitat: 
Medical
♦ Concept: Medical h/w
and supplies to 
launch in rack (must 
meet launch mass 
constraints) 
ALS/Trauma 
stabilization kit
♦ Portable Imager (U/S)
♦ Telemedicine 
Workstation
♦ Medical procedure kit
• Dental
• Laceration repair
• Acute Care pack
Medical/Exercise/Environmental Monitoring 
System Mass and Volume Allocation-GFE
Lunar Outpost Outpost- Long duration 
Habitat: 
– Periodic Health Status via Telemedicine 
WS
– Exercise/Fitness station
– Improved autonomy for Contingency 
Response
– Environmental Contingency Response
Medical h/w and supplies to outfit the 
HabiTank:
Telemedicine Workstation
Diagnostic Capability
Portable Imager (U/S)
Advanced Life Support/
Trauma stabilization kit
Medical procedure kit
Dental
Laceration repair
Acute Care pack
Size- Approx. ISS ISO Rack: 0.5-0.75 M2 
Volume TBD 0.5-0.75 CTBE
Mass 10-20 kg
Biomedical and Crew Performance Aspects of 
the Exploration EVA system: EVA Physiology, 
Systems and Performance Project
Mike Gernhardt/Jeff Jones (JSC- CB;SK/ SD)
Kevin MacNeil; Jennifer Jadwick (Wyle)
Biomedical and Crew Performance 
Aspects of the Exploration EVA System
♦ Goal  to provide the biomedical data to drive suit design 
decisions that optimize human performance and minimize suit 
induced trauma
♦ Predictive models of metabolic costs and biomechanical 
parameters based on gravity levels, suit  weight and mass, 
kinematics, pressure and center of gravity
♦ No overhead biomedical harness- built into thermal 
garment/LCVG
VaSIMR (Variable Specific Impulse Magnetoplasma Rocket) engines do not use chemical 
reactions to produce rocket thrust. Instead the hydrogen is turned into plasma, a super hot gas at 
temperatures higher than the interior of the Sun. The plasma is created by electromagnetic waves 
in a magnetic chamber and expelled through a magnetic nozzle. Advanced superconducting 
magnets generate the strong fields required by the engine. 
Getting there faster is the best countermeasure medical could hope for!!!!
CEV to Mars Orbit or likely to Mars Transit 
Vehicle and back
♦ Concept to have access to a Mars transit vehicle after 
TMI until Mars descent
♦ Concept pre-position Mars habitat on surface and 
conduct check-out
♦ ISRU/Power/LSS support
♦ Preventive Medicine station
• PEx, Labs, Countermeasures
♦ Contingency Management
• Portable Imager (U/S)
• Telemedicine Workstation
• Medical procedure kit
♦ Mars Surface
• Autonomous Medical Prevention and Care
• Surgical Capability
POTENTIAL CEV LANDING AREAS: CONUS 
and PACIFIC (from M. Chandler, et al) Nominal Potential Landings
Developing Medical Support Systems
♦ Preventative Health Strategy
• Countermeasures: Exercise, Pre-breathe, 
Pharmacologic, Artificial Gravity
♦Autonomous Care
• Smart Systems with Decision Support
• Microbiology/Synergy with Astrobiology
• Telemedical Augmentation
♦Analog Sites- Devon Island, HMP
• Lessons Being Learned
Chain of Care
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Prevention: pre- and in-flight medical screening, health stabilization, and in-flight 
countermeasures and environmental monitoring
Diagnose: in-flight diagnostic capabilities
Treat: in-flight therapeutic capabilities
Stabilize: prepare patient for stresses of transport and medical capabilities of vehicle
Transport: rapid deorbit capability (Shuttle, Soyuz, modified Soyuz)
Stabilize/Transport/Hospital: return to earth with location and extraction by ground 
forces, preparation for and transport to Hospital, terminating in arrival at care location
Countermeasures- Exercise
Due to measured de-conditioning in even short 
duration space missions, an exercise device is 
felt to be needed by the ECP to 
protect/facilitate:
Cardiovascular fitness – to maintain overall 
fitness level, aid in ambulation during G-
transitions, and to minimize fatigue
Muscle strength and endurance – to 
complete both nominal and contingency 
mission tasks (e.g., lunar rover failure 
requiring “walk back” of distances up to 
10km; post landing egress)
Muscle recovery – from strenuous tasks or 
confined postures
Other possible system benefits – psycho/social, 
postural stability
A multifunctional exercise device to protect the 
maximum number of physiological systems?
Medical Capabilities Envisioned to Support 
Exploratory Class Space Flight Implications for the 
Future
♦ Small steps needed for diagnostic 
imaging upgrade/miniaturization
♦ Still need a giant leap for the autonomous 
medical system to support Lunar 
Colonies and Mars Exploration
♦ Plenty of work for all that are interested in 
Medical Technology Development
♦ Medical Suite in Habitat and Pressurized 
Rover
♦ Remote/ Automated Diagnostics
• Vital Signs
• Imaging
• Laboratory
♦ Non-Invasive monitors/sensors
♦ Telemedicine
• Enhanced TIP for consultation to Earth
• Telerobotics
• Computer-based diagnostic and 
treatment algorithms; virtual consultant
♦ Emergency Surgical Capability
Medical Capabilities Envisioned to Support 
Exploratory Class Space Flight Implications for the 
Future
♦ “ALL”
• Autonomous
• Light (modular) 
• Lean 
Medical Kit Size Comparison
Analog Exploration Environments
♦ Backyard/Nearby
• Rockpile
• Desert RATS
♦ Remote/Extreme Environments
• Devon Island, Haughton-Mars 
Crater 
• NEEMO
• Antarctica- Coastal and Polar 
Stations
♦ Flight
• Zero-g Aircraft
• ISS
Docs are operational oriented and 
focused on developing experienced-
based confidence in medical support 
system
Many are ex- or current military and/or 
have experience in expeditionary 
support
NEEMO
♦ Remote location, not easily accessible
♦ Transient Buoyancy- gravity offset, but hyperbaric
♦ Operationally focused- multiple “EVA’s”/day & several 
days/week
• Remote guidance utilized heavily
Haughton Crater, Devon Island
“The closest thing to being on Mars without 
leaving Earth”
HMP as a Moon/Mars Analog
♦ Lunar Surface Operations
• To ensure operational success and 
optimize performance of the crews:  
“Allow adequate time to practice mission 
activities in a variety of environments 
including good analogs that allows 
preparation for off-nominal events”
Apollo Med Ops Project Apollo 16 Geological field training in New Mexico
Apollo 12 Lunar Lander Training 
Vehicle (LLTV) Ellington Field
Apollo 17 Lunar Surface Activity 
training at KSC
Suit Mobility/Functionality 
Tests
Field Evaluations of Hamilton Sundstrand’s Concept Spacesuit for Advanced Planetary Exploration

